Humana Q4 2022 Earnings Report
Key Takeaways
Humana reported its Q4 2022 financial results, with a GAAP loss per share of $0.12 and an adjusted EPS of $1.62. The company announced FY 2023 EPS guidance of at least $27.57 on a GAAP basis and at least $28.00 on an Adjusted basis. Humana completed realignment into two segments, Insurance and CenterWell.
Reported 4Q22 loss per share of $0.12 on a GAAP basis, Adjusted EPS of $1.62; reports full year (FY) 2022 EPS of $22.08 on a GAAP basis, $25.24 on an Adjusted basis
Announced FY 2023 EPS guidance of at least $27.57 on a GAAP basis; at least $28.00 on an Adjusted basis
Affirmed strong 2023 individual Medicare Advantage membership growth of at least 625,000, or 13.7 percent growth over FY 2022 ending membership; anticipates growth to be meaningfully higher than the industry growth
Completed realignment into two segments, Insurance and CenterWell, to drive greater collaboration and synergistic growth across the enterprise
Humana
Humana
Forward Guidance
The company provided its GAAP and Adjusted EPS guidance for the year ending December 31, 2023 (FY 2023)
Positive Outlook
- FY 2023 GAAP EPS guidance of at least $27.57
- FY 2023 Adjusted EPS guidance of at least $28.00
- Amortization of identifiable intangibles: $0.55
- Tax impact of non-GAAP adjustments: ($0.12)